IBDEI01R ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1859,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1859,1,1,0)
 ;;=1^J9360
 ;;^UTILITY(U,$J,358.3,1859,1,3,0)
 ;;=3^Vinblastine Sulfate (Velban) 1mg
 ;;^UTILITY(U,$J,358.3,1860,0)
 ;;=J9370^^21^158^37^^^^1
 ;;^UTILITY(U,$J,358.3,1860,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1860,1,1,0)
 ;;=1^J9370
 ;;^UTILITY(U,$J,358.3,1860,1,3,0)
 ;;=3^Vincristine Sulfate(VCR) 1mg
 ;;^UTILITY(U,$J,358.3,1861,0)
 ;;=J9390^^21^158^32^^^^1
 ;;^UTILITY(U,$J,358.3,1861,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1861,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,1861,1,3,0)
 ;;=3^Navelbine 10mgs
 ;;^UTILITY(U,$J,358.3,1862,0)
 ;;=J9001^^21^158^16^^^^1
 ;;^UTILITY(U,$J,358.3,1862,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1862,1,1,0)
 ;;=1^J9001
 ;;^UTILITY(U,$J,358.3,1862,1,3,0)
 ;;=3^Doxorubicin,liposome,10mg
 ;;^UTILITY(U,$J,358.3,1863,0)
 ;;=J9171^^21^158^14^^^^1
 ;;^UTILITY(U,$J,358.3,1863,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1863,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,1863,1,3,0)
 ;;=3^Docetaxel 1 mg
 ;;^UTILITY(U,$J,358.3,1864,0)
 ;;=J9070^^21^158^11^^^^1
 ;;^UTILITY(U,$J,358.3,1864,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1864,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,1864,1,3,0)
 ;;=3^Cyclophosphamide 100mg Inj
 ;;^UTILITY(U,$J,358.3,1865,0)
 ;;=J9351^^21^158^35^^^^1
 ;;^UTILITY(U,$J,358.3,1865,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1865,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,1865,1,3,0)
 ;;=3^Topotecan 0.1mg
 ;;^UTILITY(U,$J,358.3,1866,0)
 ;;=J9035^^21^158^3^^^^1
 ;;^UTILITY(U,$J,358.3,1866,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1866,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,1866,1,3,0)
 ;;=3^Bevacizumab Inj,10mg
 ;;^UTILITY(U,$J,358.3,1867,0)
 ;;=J9041^^21^158^5^^^^1
 ;;^UTILITY(U,$J,358.3,1867,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1867,1,1,0)
 ;;=1^J9041
 ;;^UTILITY(U,$J,358.3,1867,1,3,0)
 ;;=3^Bortezomib Inj, 0.1mg
 ;;^UTILITY(U,$J,358.3,1868,0)
 ;;=J9045^^21^158^8^^^^1
 ;;^UTILITY(U,$J,358.3,1868,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1868,1,1,0)
 ;;=1^J9045
 ;;^UTILITY(U,$J,358.3,1868,1,3,0)
 ;;=3^Carboplatin Inj, 50mg
 ;;^UTILITY(U,$J,358.3,1869,0)
 ;;=J9055^^21^158^9^^^^1
 ;;^UTILITY(U,$J,358.3,1869,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1869,1,1,0)
 ;;=1^J9055
 ;;^UTILITY(U,$J,358.3,1869,1,3,0)
 ;;=3^Cetuximab Inj, 10mg
 ;;^UTILITY(U,$J,358.3,1870,0)
 ;;=J8530^^21^158^12^^^^1
 ;;^UTILITY(U,$J,358.3,1870,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1870,1,1,0)
 ;;=1^J8530
 ;;^UTILITY(U,$J,358.3,1870,1,3,0)
 ;;=3^Cyclophosphamide Oral, 25mg
 ;;^UTILITY(U,$J,358.3,1871,0)
 ;;=J9206^^21^158^25^^^^1
 ;;^UTILITY(U,$J,358.3,1871,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1871,1,1,0)
 ;;=1^J9206
 ;;^UTILITY(U,$J,358.3,1871,1,3,0)
 ;;=3^Irinotecan Inj, 20mg
 ;;^UTILITY(U,$J,358.3,1872,0)
 ;;=J0135^^21^158^1^^^^1
 ;;^UTILITY(U,$J,358.3,1872,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1872,1,1,0)
 ;;=1^J0135
 ;;^UTILITY(U,$J,358.3,1872,1,3,0)
 ;;=3^Adalimumab Inj 20mg
 ;;^UTILITY(U,$J,358.3,1873,0)
 ;;=P9010^^21^159^22^^^^1
 ;;^UTILITY(U,$J,358.3,1873,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1873,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,1873,1,3,0)
 ;;=3^Whole Blood,Ea Unit
 ;;^UTILITY(U,$J,358.3,1874,0)
 ;;=P9012^^21^159^4^^^^1
 ;;^UTILITY(U,$J,358.3,1874,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1874,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,1874,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,1875,0)
 ;;=P9016^^21^159^18^^^^1
 ;;^UTILITY(U,$J,358.3,1875,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1875,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,1875,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,1876,0)
 ;;=P9017^^21^159^6^^^^1
 ;;^UTILITY(U,$J,358.3,1876,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1876,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,1876,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,1877,0)
 ;;=P9019^^21^159^10^^^^1
 ;;^UTILITY(U,$J,358.3,1877,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1877,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,1877,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,1878,0)
 ;;=P9021^^21^159^20^^^^1
 ;;^UTILITY(U,$J,358.3,1878,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1878,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,1878,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,1879,0)
 ;;=P9022^^21^159^21^^^^1
 ;;^UTILITY(U,$J,358.3,1879,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1879,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,1879,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,1880,0)
 ;;=P9023^^21^159^5^^^^1
 ;;^UTILITY(U,$J,358.3,1880,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1880,1,1,0)
 ;;=1^P9023
 ;;^UTILITY(U,$J,358.3,1880,1,3,0)
 ;;=3^Frozen Plasma,Pooled,SD
 ;;^UTILITY(U,$J,358.3,1881,0)
 ;;=P9034^^21^159^12^^^^1
 ;;^UTILITY(U,$J,358.3,1881,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1881,1,1,0)
 ;;=1^P9034
 ;;^UTILITY(U,$J,358.3,1881,1,3,0)
 ;;=3^Platelets,Pheresis
 ;;^UTILITY(U,$J,358.3,1882,0)
 ;;=P9035^^21^159^8^^^^1
 ;;^UTILITY(U,$J,358.3,1882,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1882,1,1,0)
 ;;=1^P9035
 ;;^UTILITY(U,$J,358.3,1882,1,3,0)
 ;;=3^Platelet Pheres Leuko Reduced
 ;;^UTILITY(U,$J,358.3,1883,0)
 ;;=P9036^^21^159^9^^^^1
 ;;^UTILITY(U,$J,358.3,1883,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1883,1,1,0)
 ;;=1^P9036
 ;;^UTILITY(U,$J,358.3,1883,1,3,0)
 ;;=3^Platelet Pheres Leukoredu Irrad
 ;;^UTILITY(U,$J,358.3,1884,0)
 ;;=P9038^^21^159^16^^^^1
 ;;^UTILITY(U,$J,358.3,1884,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1884,1,1,0)
 ;;=1^P9038
 ;;^UTILITY(U,$J,358.3,1884,1,3,0)
 ;;=3^RBC Irradiated
 ;;^UTILITY(U,$J,358.3,1885,0)
 ;;=P9039^^21^159^15^^^^1
 ;;^UTILITY(U,$J,358.3,1885,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1885,1,1,0)
 ;;=1^P9039
 ;;^UTILITY(U,$J,358.3,1885,1,3,0)
 ;;=3^RBC Deglycerolized
 ;;^UTILITY(U,$J,358.3,1886,0)
 ;;=P9040^^21^159^17^^^^1
 ;;^UTILITY(U,$J,358.3,1886,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1886,1,1,0)
 ;;=1^P9040
 ;;^UTILITY(U,$J,358.3,1886,1,3,0)
 ;;=3^RBC Leuko Reduced Irradiated
 ;;^UTILITY(U,$J,358.3,1887,0)
 ;;=P9044^^21^159^3^^^^1
 ;;^UTILITY(U,$J,358.3,1887,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1887,1,1,0)
 ;;=1^P9044
 ;;^UTILITY(U,$J,358.3,1887,1,3,0)
 ;;=3^Cryoprecip Reduced Plasma
 ;;^UTILITY(U,$J,358.3,1888,0)
 ;;=P9051^^21^159^1^^^^1
 ;;^UTILITY(U,$J,358.3,1888,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1888,1,1,0)
 ;;=1^P9051
 ;;^UTILITY(U,$J,358.3,1888,1,3,0)
 ;;=3^Blood,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,1889,0)
 ;;=P9052^^21^159^11^^^^1
 ;;^UTILITY(U,$J,358.3,1889,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1889,1,1,0)
 ;;=1^P9052
 ;;^UTILITY(U,$J,358.3,1889,1,3,0)
 ;;=3^Platelets,HLA-M,L/R,Ea Unit
 ;;^UTILITY(U,$J,358.3,1890,0)
 ;;=P9053^^21^159^14^^^^1
 ;;^UTILITY(U,$J,358.3,1890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1890,1,1,0)
 ;;=1^P9053
 ;;^UTILITY(U,$J,358.3,1890,1,3,0)
 ;;=3^Plt,Pher,L/R CMV-Neg,Irr
 ;;^UTILITY(U,$J,358.3,1891,0)
 ;;=P9054^^21^159^2^^^^1
 ;;^UTILITY(U,$J,358.3,1891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1891,1,1,0)
 ;;=1^P9054
 ;;^UTILITY(U,$J,358.3,1891,1,3,0)
 ;;=3^Blood,L/R,Froz/Degly/Wash
 ;;^UTILITY(U,$J,358.3,1892,0)
 ;;=P9055^^21^159^13^^^^1
 ;;^UTILITY(U,$J,358.3,1892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1892,1,1,0)
 ;;=1^P9055
 ;;^UTILITY(U,$J,358.3,1892,1,3,0)
 ;;=3^Plt,Aph/Pher,L/R,CMV-Neg
 ;;^UTILITY(U,$J,358.3,1893,0)
 ;;=P9058^^21^159^19^^^^1
 ;;^UTILITY(U,$J,358.3,1893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1893,1,1,0)
 ;;=1^P9058
 ;;^UTILITY(U,$J,358.3,1893,1,3,0)
 ;;=3^RBC,L/R,CMV-Neg,Irrad
 ;;^UTILITY(U,$J,358.3,1894,0)
 ;;=P9059^^21^159^7^^^^1
 ;;^UTILITY(U,$J,358.3,1894,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1894,1,1,0)
 ;;=1^P9059
 ;;^UTILITY(U,$J,358.3,1894,1,3,0)
 ;;=3^Plasma,Frz Between 8-24hrs
 ;;^UTILITY(U,$J,358.3,1895,0)
 ;;=38220^^21^160^1^^^^1
 ;;^UTILITY(U,$J,358.3,1895,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1895,1,1,0)
 ;;=1^38220
 ;;^UTILITY(U,$J,358.3,1895,1,3,0)
 ;;=3^BONE MARROW ASPIRATION
 ;;^UTILITY(U,$J,358.3,1896,0)
 ;;=38221^^21^160^2^^^^1
 ;;^UTILITY(U,$J,358.3,1896,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1896,1,1,0)
 ;;=1^38221
 ;;^UTILITY(U,$J,358.3,1896,1,3,0)
 ;;=3^BONE MARROW BIOPSY
 ;;^UTILITY(U,$J,358.3,1897,0)
 ;;=19000^^21^160^3^^^^1
 ;;^UTILITY(U,$J,358.3,1897,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1897,1,1,0)
 ;;=1^19000
 ;;^UTILITY(U,$J,358.3,1897,1,3,0)
 ;;=3^BREAST CYST ASPIRATION
 ;;^UTILITY(U,$J,358.3,1898,0)
 ;;=19100^^21^160^4^^^^1
 ;;^UTILITY(U,$J,358.3,1898,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1898,1,1,0)
 ;;=1^19100
 ;;^UTILITY(U,$J,358.3,1898,1,3,0)
 ;;=3^BREAST NEEDLE BIOPSY
 ;;^UTILITY(U,$J,358.3,1899,0)
 ;;=10022^^21^160^5^^^^1
 ;;^UTILITY(U,$J,358.3,1899,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1899,1,1,0)
 ;;=1^10022
 ;;^UTILITY(U,$J,358.3,1899,1,3,0)
 ;;=3^FNA W/IMAGE
 ;;^UTILITY(U,$J,358.3,1900,0)
 ;;=10021^^21^160^6^^^^1
 ;;^UTILITY(U,$J,358.3,1900,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1900,1,1,0)
 ;;=1^10021
 ;;^UTILITY(U,$J,358.3,1900,1,3,0)
 ;;=3^FNA W/O IMAGE
 ;;^UTILITY(U,$J,358.3,1901,0)
 ;;=49082^^21^160^7^^^^1
 ;;^UTILITY(U,$J,358.3,1901,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1901,1,1,0)
 ;;=1^49082
 ;;^UTILITY(U,$J,358.3,1901,1,3,0)
 ;;=3^PARACENTESIS
 ;;^UTILITY(U,$J,358.3,1902,0)
 ;;=99195^^21^160^8^^^^1
 ;;^UTILITY(U,$J,358.3,1902,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1902,1,1,0)
 ;;=1^99195
 ;;^UTILITY(U,$J,358.3,1902,1,3,0)
 ;;=3^PHLEBOTOMY
 ;;^UTILITY(U,$J,358.3,1903,0)
 ;;=J2060^^21^161^26^^^^1
 ;;^UTILITY(U,$J,358.3,1903,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,1903,1,1,0)
 ;;=1^J2060
 ;;^UTILITY(U,$J,358.3,1903,1,3,0)
 ;;=3^Lorazepam 2mg
 ;;^UTILITY(U,$J,358.3,1904,0)
 ;;=J3420^^21^161^41^^^^1
